Ken Fisher’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-159,734
Closed -$20M 983
2020
Q4
$20M Sell
159,734
-5,150
-3% -$576K 0.02% 300
2020
Q3
$16.7M Sell
164,884
-19,042
-10% -$1.94M 0.01% 292
2020
Q2
$17.9M Buy
183,926
+20,039
+12% +$1.86M 0.02% 283
2020
Q1
$13.6M Sell
163,887
-8,555
-5% -$834K 0.02% 273
2019
Q4
$19.2M Buy
172,442
+25,065
+17% +$2.58M 0.02% 282
2019
Q3
$14.6M Buy
147,377
+5,850
+4% +$581K 0.02% 316
2019
Q2
$14M Buy
141,527
+29,028
+26% +$2.77M 0.02% 327
2019
Q1
$12.4M Buy
112,499
+30,421
+37% +$3.18M 0.01% 328
2018
Q4
$7.55M Buy
82,078
+57,703
+237% +$5.84M 0.01% 370
2018
Q3
$2.69M Sell
24,375
-3,975
-14% -$414K ﹤0.01% 492
2018
Q2
$2.65M Sell
28,350
-30
-0.1% -$2.58K ﹤0.01% 507
2018
Q1
$2.35M Sell
28,380
-5,170
-15% -$459K ﹤0.01% 510
2017
Q4
$3.06M Sell
33,550
-9,909
-23% -$824K ﹤0.01% 485
2017
Q3
$3.31M Buy
+43,459
New +$3.28M ﹤0.01% 448
2017
Q1
Sell
-8,075
Closed -$445K 758
2016
Q4
$445K Buy
+8,075
New +$443K ﹤0.01% 575
2016
Q3
Sell
-5,244
Closed -$225K 747
2016
Q2
$225K Buy
5,244
+127
+2% +$5.85K ﹤0.01% 648
2016
Q1
$248K Buy
+5,117
New +$216K ﹤0.01% 633

Other funds holding PRAH

Ken Fisher's PRAH Position: Q1 2021 in Review

Ken Fisher sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 159,734 shares — an estimated $20M sold.

Ken Fisher first reported a position in PRAH in Q1 2016 and held it in 17 quarters. The position peaked at $20M in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Ken Fisher reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ken Fisher sold 159,734 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $20M.
  • Ken Fisher first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 17 quarters.
  • Ken Fisher's PRA Health Sciences, Inc. position peaked at $20M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Fisher Asset Management's 13F filing for Q1 2021, filed 27 Apr 2021.